Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease
- PMID: 28017827
- PMCID: PMC5466467
- DOI: 10.1016/j.jalz.2016.11.003
Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease
Abstract
Introduction: The presence of cerebrovascular pathology may increase the risk of clinical diagnosis of Alzheimer's disease (AD).
Methods: We examined excess risk of incident clinical diagnosis of AD (probable and possible AD) posed by the presence of lacunes and large infarcts beyond AD pathology using data from the Statistical Modeling of Aging and Risk of Transition study, a consortium of longitudinal cohort studies with more than 2000 autopsies. We created six mutually exclusive pathology patterns combining three levels of AD pathology (low, moderate, or high AD pathology) and two levels of vascular pathology (without lacunes and large infarcts or with lacunes and/or large infarcts).
Results: The coexistence of lacunes and large infarcts results in higher likelihood of clinical diagnosis of AD only when AD pathology burden is low.
Discussion: Our results reinforce the diagnostic importance of AD pathology in clinical AD. Further harmonization of assessment approaches for vascular pathologies is required.
Keywords: Alzheimer's disease pathology; Community sample; Population Attributable Risk%; SMART consortium; Vascular pathology.
Copyright © 2016 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.Curr Alzheimer Res. 2020;17(13):1167-1176. doi: 10.2174/1567205018666210212160902. Curr Alzheimer Res. 2020. PMID: 33583381 Free PMC article.
-
Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.J Alzheimers Dis. 2016 Oct 18;54(4):1607-1618. doi: 10.3233/JAD-160425. J Alzheimers Dis. 2016. PMID: 27589527
-
The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.J Alzheimers Dis. 2016;49(2):531-45. doi: 10.3233/JAD-150252. J Alzheimers Dis. 2016. PMID: 26444761 Free PMC article.
-
Alzheimer disease and cerebrovascular pathology: an update.J Neural Transm (Vienna). 2002 May;109(5-6):813-36. doi: 10.1007/s007020200068. J Neural Transm (Vienna). 2002. PMID: 12111471 Review.
-
The overlap between vascular disease and Alzheimer's disease--lessons from pathology.BMC Med. 2014 Nov 11;12:206. doi: 10.1186/s12916-014-0206-2. BMC Med. 2014. PMID: 25385447 Free PMC article. Review.
Cited by
-
"Exceptions that prove the rule"-Why have clinical trials failed to show efficacy of risk factor interventions suggested by observational studies of the dementia-Alzheimer's disease syndrome?Alzheimers Dement. 2022 Mar;18(3):389-392. doi: 10.1002/alz.12633. Epub 2022 Mar 4. Alzheimers Dement. 2022. PMID: 35245406 Free PMC article. No abstract available.
-
Letter.Alzheimers Dement (Amst). 2017 Nov 21;9:84-87. doi: 10.1016/j.dadm.2017.11.004. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 29255790 Free PMC article. No abstract available.
-
Alzheimer disease blood biomarkers: considerations for population-level use.Nat Rev Neurol. 2024 Aug;20(8):495-504. doi: 10.1038/s41582-024-00989-1. Epub 2024 Jun 11. Nat Rev Neurol. 2024. PMID: 38862788 Free PMC article. Review.
-
The association of MIND diet with cognitive resilience to neuropathologies.Alzheimers Dement. 2023 Aug;19(8):3644-3653. doi: 10.1002/alz.12982. Epub 2023 Feb 28. Alzheimers Dement. 2023. PMID: 36855023 Free PMC article.
-
Cerebrovascular Alterations in Alzheimer Disease.Circ Res. 2018 Aug 3;123(4):406-408. doi: 10.1161/CIRCRESAHA.118.313400. Circ Res. 2018. PMID: 30355253 Free PMC article. Review.
References
-
- Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014;13:788–794. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 AG053760/AG/NIA NIH HHS/United States
- K25 AG043546/AG/NIA NIH HHS/United States
- RF1 AG015819/AG/NIA NIH HHS/United States
- R01 AG034119/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- R01 AG038651/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- P01 AG043362/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P01 AG026276/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical